Literature DB >> 27291510

Morphologic remodeling of left atrial appendage in patients with atrial fibrillation.

Hideyuki Kishima1, Takanao Mine2, Satoshi Takahashi2, Kenki Ashida2, Masaharu Ishihara2, Tohru Masuyama2.   

Abstract

BACKGROUND: Left atrial appendage (LAA) has recently been of significant focus because of the development of the LAA closure device.
OBJECTIVE: The purpose of this study was to test the hypothesis that atrial fibrillation (AF) leads to a morphologic change in the LAA and to investigate the characteristics of LAA morphology in patients with and without AF.
METHODS: This retrospective study included 225 patients (persistent AF [PeAF], n = 76; paroxysmal AF [PAF], n = 70; control, n = 79] who underwent echocardiography and computed tomography (CT). All patients were classified into 2 types (chicken wing [CW] or non-chicken wing [non-CW]) using CT.
RESULTS: The prevalence of non-CW-type LAA was 39.5%, 15.7%, and 8.9% in the PeAF, PAF, and control groups, respectively. Patients in the PeAF group had a higher prevalence of non-CW-type LAA than did those in the PAF and control groups (P = .0014 and P <.0001, respectively). In addition, all patients were divided into 5 groups based on the type of cardiac rhythm (PeAF, PAF, or sinus rhythm) and left atrial volume index (cutoff value; 34 mL/m(2)): group A (Control), group B (PAF/Small-LA), group C (PAF/Large-LA), group D (PeAF/Small-LA), group E (PeAF/Large-LA). The prevalence of non-CW-type LAA was 9%, 14%, 17%, 29%, and 41% in groups A, B, C, D, and E, respectively.
CONCLUSION: Presence of persistent AF was associated with a higher prevalence of non-chicken wing-type LAA. Our analysis suggests that remodeling in patients with persistent AF can lead to a change in LAA morphology.
Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Coronary computed tomography; Left atrial appendage; Morphologic change; Remodeling

Mesh:

Year:  2016        PMID: 27291510     DOI: 10.1016/j.hrthm.2016.06.009

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  6 in total

1.  Left Atrial Appendage characteristics in patients with Persistent Atrial Fibrillation undergoing catheter ablation (LAAPAF Study).

Authors:  Enes E Gul; Usama Boles; Sohaib Haseeb; Justin Flood; Ayuish Bansal; Benedict Glover; Damian Redfearn; Chris Simpson; Hoshiar Abdollah; Adrian Baranchuk; Kevin A Michael
Journal:  J Atr Fibrillation       Date:  2017-02-28

2.  Statistical shape analysis of the left atrial appendage predicts stroke in atrial fibrillation.

Authors:  Erik T Bieging; Alan Morris; Lowell Chang; Lilas Dagher; Nassir F Marrouche; Joshua Cates
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-06       Impact factor: 2.316

Review 3.  Left Atrial Appendage Anatomy: Implications for Endocardial Catheter-based Device Closure.

Authors:  Abhishek Maan; E Kevin Heist
Journal:  J Innov Card Rhythm Manag       Date:  2020-07-15

4.  Left atrial and left atrial appendage remodeling after transcatheter aortic valve replacement: Preliminary results.

Authors:  Tian-Yuan Xiong; Fei Chen; Yi-Jian Li; Yuan Feng; Mao Chen
Journal:  Cardiol J       Date:  2021-06-24       Impact factor: 2.737

5.  Impact of atrial fibrillation pattern on outcomes after left atrial appendage closure: lessons from the prospective LAARGE registry.

Authors:  Shinwan Kany; Johannes Brachmann; Thorsten Lewalter; Ibrahim Akin; Horst Sievert; Uwe Zeymer; Jakob Ledwoch; Hüseyin Ince; Dierk Thomas; Matthias Hochadel; Jochen Senges; Paulus Kirchhof; Andreas Rillig
Journal:  Clin Res Cardiol       Date:  2021-05-27       Impact factor: 6.138

6.  Diabetes induces remodeling of the left atrial appendage independently of atrial fibrillation in a rodent model of type-2 diabetes.

Authors:  Or Yosefy; Barucha Sharon; Chana Yagil; Mark Shlapoberski; Alejandro Livoff; Ilana Novitski; Ronen Beeri; Yoram Yagil; Chaim Yosefy
Journal:  Cardiovasc Diabetol       Date:  2021-07-23       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.